Changmao Biochemical Engineering Company Limited Provided consolidated net profit attributable to the shareholders of the Company for the six months ended 30 June 2023 of less than RMB 5,000,000, which represents a significant decline as compared with the consolidated net profit attributable to the shareholders of the Company of approximately RMB 40,880,000 for the six months ended 30 June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 HKD | 0.00% | -2.27% | -27.12% |
03-26 | Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-29 | Changmao Biochemical Engineering to Swing to Loss in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
-27.12% | 29.2M | |
+5.41% | 106B | |
-4.31% | 64.74B | |
+73.33% | 49.34B | |
+17.24% | 39.15B | |
+6.13% | 32.86B | |
+12.77% | 20.29B | |
+15.03% | 17.21B | |
+19.06% | 15.28B | |
+6.28% | 14.58B |
- Stock Market
- Equities
- 954 Stock
- News Changmao Biochemical Engineering Company Limited
- Changmao Biochemical Engineering Company Limited Provides Consolidated Net Profit Attributable Guidance for the Six Months Ended 30 June 2023